688767.SH
博拓生物
SSE · Healthcare · Biotechnology · CN
CNY 35.16
−13.65%Margins
Gross margin
46.3%
EBITDA margin
16.6%
EBIT margin
5.9%
Net margin
6.7%
FCF margin
-18.1%
1.3%
Return on equity
1.2%
Return on assets
1.1%
Return on invested capital
0.18x
Asset turnover
CNY 60.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026